Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) |
| BNF code | 0601023Y0BCACAE |
| Virtual Medicinal Product | Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices |
| Name | Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens |
| Abbreviated name | Bydureon BCise 2mg/0.85ml prolonged-release inj pf pens |
| Date of name applicability | 26 Feb 2020 |
| Previous name | Bydureon 2mg/0.85ml prolonged-release suspension for injection pre-filled pens |
| Supplier | AstraZeneca UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) 4 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.